TEST:

Archer™ VARIANTPlex™ Lymphoma panel

ARID1A (AT-rich interaction domain 1A), ATM (ATM serine/threonine kinase), B2M (Beta-2-microglobulin), BCL2 (B-cell CLL/lymphoma 2), BIRC3 (Baculoviral IAP repeat containing 3), BRAF (B-raf proto-oncogene), BTK (Bruton Tyrosine Kinase), CARD11 (Caspase Recruitment Domain Family Member 11), CCND1 (Cyclin D1), CD28 (CD28 Molecule), CD79A (CD79a Molecule), CD79B (CD79b Molecule), CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), CDKN2B (Cyclin Dependent Kinase Inhibitor 2B), CREBBP (CREB binding protein), CXCR4 (Chemokine (C-X-C motif) receptor 4), DNMT3A (DNA methyltransferase 1), EP300 (E1A binding protein p300), EZH2 (Enhancer of zeste 2 polycomb repressive complex 2 subunit), FOXO1 (Forkhead box O1), ID3 (Inhibitor Of DNA Binding 3, HLH Protein), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), JAK1 (Janus Kinase 1), JAK3 (Janus Kinase 3), KMT2D (Lysine Methyltransferase 2D), MYC (V-myc avian myelocytomatosis viral oncogene homolog), MYD88 (MYD88 Innate Immune Signal Transduction Adaptor), NFKBIE (NFKB Inhibitor Epsilon), NOTCH1 (Notch 1), NOTCH2 (Notch 2), PIM1 (Pim-1 Proto-Oncogene), PLCG1 (Phospholipase C Gamma 1), PLCG2 (Phospholipase C Gamma 2), PTPRD (Protein tyrosine phosphatase receptor type D), RHOA (Ras homolog family member A), SF3B1 (Splicing Factor 3b Subunit 1), SOCS1 (Suppressor Of Cytokine Signaling 1), STAT3 (Signal Transducer And Activator Of Transcription 3), STAT5B (Signal Transducer And Activator Of Transcription 5B), STAT6 (Signal transducer and activator of transcription 6), TCF3 (Transcription Factor 3), TET2 (Tet Methylcytosine Dioxygenase 2), TNFAIP3 (TNF Alpha Induced Protein 3), TP53 (Tumor protein P53), XPO1 (Exportin 1)